Table 3.
All-cause mortality of acute heart failure patients with heart failure with reduced ejection fraction according to β-blocker type at discharge in total population and propensity-matched population
| Bisoprolol | Carvedilol | Unadjusted |
Adjusteda |
|||
|---|---|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |||
| Overall population | 553 | 831 | ||||
| All-cause death | 146 (23.5) | 299 (27.5) | 1.21 (0.99–1.47) | 0.07 | 1.22 (0.98–1.52) | 0.07 |
| Propensity matched population | 508 | 508 | ||||
| All-cause death | 121 (23.8) | 133 (26.2) | 1.10 (0.86–1.40) | 0.47 | 1.19 (0.93–1.53) | 0.17 |
Values are presented as number (%).
HR, hazard ratio; CI, confidence interval.
a
Adjusted variables included age, male sex, hypertension, diabetes mellitus, history of heart failure admission, ischemic etiology, systolic blood pressure at discharge, left ventricular ejection fraction, renin angiotensin system blocker at discharge, and aldosterone antagonist at discharge.